Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Swine Flu Could Benefit Some Biomedical Companies, Local Biotechs Are Looking Healthier, Arena Happy With Obesity Drug Results, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/24/09 |
San Diego
|
|
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs
|
Luke Timmerman |
09/18/09 |
San Diego
|
|
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets
|
Luke Timmerman |
08/18/09 |
San Diego
|
|
Wireless Medicine Gets $45M Booster Shot, Arena’s Weight-Loss Trial Underwhelms Wall Street, Venter’s Synthetic Genomics About to Ramp Up, & Other San Diego BizTech News
|
Bruce V. Bigelow |
04/06/09 |
San Diego
|
|
Ambrx Gets $10 Million in Venture Round
|
Juha-Pekka Tikka |
04/01/09 |
San Diego
|
|
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS
|
Luke Timmerman |
03/27/09 |
Boston
|
|
Biotech CEOs Discuss the Virtues of Going Virtual
|
Bruce V. Bigelow |
03/26/09 |
San Diego
|
|
Pacira and Histogen Disclose Layoffs, Optimer Advances Diarrhea Drug, Torrey Path Comes to Town, & More SD BizTech
|
Bruce V. Bigelow |
03/02/09 |
San Diego
|
|
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/26/09 |
Seattle
|
|
Ambrx Nails Down Partnership with Merck KGaA to Develop Multiple Sclerosis Drug
|
Luke Timmerman |
02/24/09 |
San Diego
|
|
Ambrx Aims to Create New Breed of Custom-Built Biotech Drugs
|
Luke Timmerman |
12/08/08 |
San Diego
|
|
Ambrx Garners $28,364,000 New Round
|
VentureDeal |
06/30/06 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
